SEVERE CACHEXIA IN MICE INOCULATED WITH INTERFERON-GAMMA-PRODUCING TUMOR-CELLS

被引:130
作者
MATTHYS, P
DIJKMANS, R
PROOST, P
VANDAMME, J
HEREMANS, H
SOBIS, H
BILLIAU, A
机构
[1] Laboratory of Immunobiology, Rega Institute, University of Leuven
关键词
D O I
10.1002/ijc.2910490115
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Nude mice were inoculated with CHO/IFN-gamma cells, a line of Chinese hamster ovary tumor cells, that had been genetically engineered to produce murine IFN-gamma. Severe cachexia, as evident from body weight loss and reduced food intake, occurred in these mice, but not in those injected with CHO/control cells, i.e. the original, non-IFN-gamma-producing line. The essential role of IFN-gamma in the pathogenesis of cachexia was confirmed by the demonstration that monoclonal antibodies (MAbs) against IFN-gamma, given prior to injection of the tumor cells, prevented cachexia. In addition to IFN-gamma, the presence of the tumor cells was also required for cachexia to develop. As evident from pair-feeding experiments, reduced food intake could only partially account for the rapid and extensive body-weight loss. Cachexia was characterized by a marked reduction in the amount of interscapular fat tissue. Injected tumor cells exclusively invaded intraperitoneal adipose tissue and elicited an inflammatory cell infiltrate, indicating that interscapular fat loss was due to humoral factors. Our data suggest that, among the humoral factors responsible for cancer-associated cachexia, IFN-gamma plays a prominent role.
引用
收藏
页码:77 / 82
页数:6
相关论文
共 31 条
  • [1] BECK SA, 1987, CANCER RES, V47, P5919
  • [2] BEUTLER BA, 1985, J IMMUNOL, V135, P3969
  • [3] BIBBY MC, 1987, J NATL CANCER I, V78, P539
  • [4] PROGNOSTIC EFFECT OF WEIGHT-LOSS PRIOR TO CHEMOTHERAPY IN CANCER-PATIENTS
    DEWYS, WD
    BEGG, C
    LAVIN, PT
    BAND, PR
    BENNETT, JM
    BERTINO, JR
    COHEN, MH
    DOUGLASS, HO
    ENGSTROM, PF
    EZDINLI, EZ
    HORTON, J
    JOHNSON, GJ
    MOERTEL, CG
    OKEN, MM
    PERLIA, C
    ROSENBAUM, C
    SILVERSTEIN, MN
    SKEEL, RT
    [J]. AMERICAN JOURNAL OF MEDICINE, 1980, 69 (04) : 491 - 497
  • [5] MURINE INTERFERON-GAMMA INTERLEUKIN-1 FUSION PROTEINS USED AS ANTIGENS FOR THE GENERATION OF HYBRIDOMAS PRODUCING MONOCLONAL ANTI-INTERLEUKIN-1 ANTIBODIES
    DIJKMANS, R
    MARTENS, E
    BEUKEN, E
    CORNETTE, F
    DILLEN, C
    HEREMANS, H
    BORASCHI, D
    BILLIAU, A
    [J]. CYTOKINE, 1991, 3 (02) : 134 - 140
  • [6] DIJKMANS R, 1987, J BIOL CHEM, V262, P2528
  • [7] EGGERMONT AM, 1986, CANCER IMMUNOL IMMUN, V21, P81
  • [8] CLONING OF AN INTERLEUKIN-4 INDUCIBLE GENE FROM CYTOTOXIC LYMPHOCYTES-T AND ITS IDENTIFICATION AS A LIPASE
    GRUSBY, MJ
    NABAVI, N
    WONG, H
    DICK, RF
    BLUESTONE, JA
    SCHOTZ, MC
    GLIMCHER, LH
    [J]. CELL, 1990, 60 (03) : 451 - 459
  • [9] INTERFERON-GAMMA, A MEDIATOR OF LETHAL LIPOPOLYSACCHARIDE-INDUCED SHWARTZMAN-LIKE SHOCK REACTIONS IN MICE
    HEREMANS, H
    VANDAMME, J
    DILLEN, C
    DIJKMANS, R
    BILLIAU, A
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 171 (06) : 1853 - 1869
  • [10] JABLONS D, 1990, FASEB J, pA1713